Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in ChildrenJeffrey S. Hyams, Robert N. Baldassano, Wallace Crandall et al.|Gastroenterology|2006Cited by 872
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort studySubra Kugathasan, Marla C. Dubinsky, Lee A. Denson et al.|The Lancet|2017Cited by 647
Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registryMelvin B. Heyman, Hashem B. El‐Serag, Barbara S. Kirschner et al.|The Journal of Pediatrics|2005Cited by 571
Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative ColitisJeffrey S. Hyams, Anne M. Griffiths, Lakshmi Damaraju et al.|Clinical Gastroenterology and Hepatology|2011Cited by 282
Development of extraintestinal manifestations in pediatric patients with inflammatory bowel diseaseFolashade A. Jose, Melvin B. Heyman, Elizabeth A. Garnett et al.|Inflammatory Bowel Diseases|2008Cited by 248